← VERTEX PHARMACEUTICALS INC / MA VRTX
Market Price
$505.46
Market Cap
$131.07B
P/E Ratio
32.99
Revenue (FY 2025)
↑8.9% YoY
$12.00B
3-Yr CAGR: 10.4%
Net Income
↑838.1% YoY
$3.95B
Net Margin: 32.9%
Free Cash Flow
↑504.1% YoY
$3.19B
FCF Yield: 2.44%
EPS (Diluted)
↑836.5% YoY
$15.32
Basic: $15.46
Return on Equity
Efficiency
21.2%
ROA: 463.3%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (VRTX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,702.2M | — | $1,495.4M | $-112.1M | — | $-0.46 | — | $236.1M | $179.5M | — |
| FY 2017 | $2,488.7M | +46.2% | $2,216.0M | $263.5M | +335.1% | $1.04 | +326.1% | $844.9M | $745.5M | +315.2% |
| FY 2018 | $3,047.6M | +22.5% | $2,638.1M | $2,096.9M | +695.8% | $8.09 | +677.9% | $1,270.3M | $1,174.8M | +57.6% |
| FY 2019 | $4,162.8M | +36.6% | $3,615.1M | $1,176.8M | -43.9% | $4.51 | -44.3% | $1,569.3M | $1,493.9M | +27.2% |
| FY 2020 | $6,205.7M | +49.1% | $5,469.4M | $2,711.6M | +130.4% | $10.29 | +128.2% | $3,253.5M | $2,993.7M | +100.4% |
| FY 2021 | $7,574.4M | +22.1% | $6,670.2M | $2,342.1M | -13.6% | $9.01 | -12.4% | $2,643.5M | $2,408.5M | -19.5% |
| FY 2022 | $8,930.7M | +17.9% | $7,850.4M | $3,322.0M | +41.8% | $12.82 | +42.3% | $4,129.9M | $3,925.2M | +63.0% |
| FY 2023 | $9,869.2M | +10.5% | $8,607.0M | $3,619.6M | +9.0% | $13.89 | +8.3% | $3,537.3M | $3,336.9M | -15.0% |
| FY 2024 | $11,020.1M | +11.7% | $9,489.6M | $-535.6M | -114.8% | $-2.08 | -115.0% | $-492.6M | $-790.3M | -123.7% |
| FY 2025 | $12,001.3M | +8.9% | $10,350.0M | $3,953.2M | +838.1% | $15.32 | +836.5% | $3,631.4M | $3,193.8M | +504.1% |
Valuation
Market Price
$505.46
Market Cap
$131.07B
Enterprise Value
N/A
P/E Ratio
32.99
P/B Ratio
6.87
FCF Yield
2.44%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
86.24%
Operating Margin
34.77%
Net Margin
32.94%
Return on Equity (ROE)
21.18%
Return on Assets (ROA)
463.28%
Asset Turnover
14.06x
Revenue 3-Yr CAGR
10.35%
Financial Health & Liquidity
Current Ratio
0.29
Cash Ratio
1.71
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$5.08B
Total Debt
N/A
Book Value / Share
$73.54
Cash Flow Efficiency
Operating Cash Flow
$3.63B
Capital Expenditures (CapEx)
$437.60M
Free Cash Flow
$3.19B
OCF / Revenue
30.26%
FCF / Revenue
26.61%
FCF 3-Yr CAGR
-6.64%
Per Share Metrics
EPS (Diluted)
$15.32
EPS (Basic)
$15.46
Dividends / Share
N/A
Book Value / Share
$73.54
EPS YoY Growth
836.54%
Balance Sheet (FY 2025)
Total Assets
$853.30M
Total Liabilities
$2.97B
Stockholders' Equity
$18.67B
Current Assets
$853.30M
Current Liabilities
$2.97B